Schoke Jewish Family Service

Schoke Jewish Family Service is a SAMHSA-registered addiction-treatment facility in Stamford, CT. The facility's programming is outpatient (Outpatient), not residential. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at Schoke Jewish Family Service

Schoke Jewish Family Service is an outpatient-focused program (Outpatient) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. ASAM Criteria 4e is the benchmark framework for matching patients to appropriate intensity. Most major payer medical-necessity documents reference it. An outside ASAM-aligned assessment, prior to admission, is the protection against misplacement.

Insurance and payment

Schoke Jewish Family Service accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. The operational prerequisite is written documentation: in-network status for your specific plan product, deductible accumulation, coinsurance rate, prior-authorization status. Admissions without these four documented carry material risk of post-admission financial disagreement.

Before you call

Three pre-admission questions for Schoke Jewish Family Service: (1) at what ASAM 4e level are you admitting me, and what is the clinical rationale; (2) can you provide written Verification of Benefits for my specific plan; (3) what is your MAT policy for opioid use disorder — specifically, do you continue buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Schoke Jewish Family Service offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.